Microcap Ledger SANUWAVE Health, Inc. $SNWV
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Market
- Sector
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Eden Prairie, MN
- Fiscal year end
- December 31
- Shares outstanding
- 8,602,309 [10-Q 2026-08-06]
What the company doesAI summary of filing
SANUWAVE Health, Inc. is a medical device company that develops and markets the UltraMIST system, an FDA-cleared directed energy product using low-frequency ultrasound to treat acute and chronic wounds including diabetic foot ulcers, venous leg ulcers, and pressure injuries. The company generates revenue through a razor-and-blade model, selling UltraMIST systems to hospitals, physician offices, wound centers, and other healthcare facilities, with recurring revenue from sterile single-use consumable applicators that represent approximately 58% of total revenues. The company is revenue-generating, with 2025 revenues of $44.1 million (35% increase from 2024) and 1,292 active systems in the field as of December 31, 2025. UltraMIST has Category 1 reimbursement from CMS under code 97610 and is backed by a portfolio of over 60 patents. [10-K 2026-03-26]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $19.36M | −$2.12M | $822.0K | $9.38M | [10-Q 2026-08-06] |
| FY ended Dec 2025 | $44.05M | $11.81M | $3.88M | $11.96M | [10-K 2026-03-26] |
| FY ended Dec 2024 | $32.63M | −$33.08M | $2.46M | $10.24M | [10-K 2026-03-26] |
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-11-06 | 8,534,151 | [10-Q 2024-11-07] |
| 2025-03-18 | 8,548,473 | [10-K 2025-03-20] |
| 2025-05-05 | 8,555,616 | [10-Q 2025-05-08] |
| 2025-08-04 | 8,568,005 | [10-Q 2025-08-07] |
| 2025-11-03 | 8,576,164 | [10-Q 2025-11-06] |
| 2026-03-24 | 8,594,209 | [10-K 2026-03-26] |
| 2026-05-08 | 8,598,976 | [10-Q 2026-05-12] |
| 2026-08-04 | 8,602,309 | [10-Q 2026-08-06] |
- Shelf registration
- S-1 filed 2024-12-03; declared effective 2024-12-19 [S-1 2024-12-03]
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2026-09-25. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2026-09-25 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2026-09-25] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-09-25 | 8-K | Listing notice or transfer |
| 2026-08-14 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-06 | 8-K | Results of operations |
| 2026-08-06 | 10-Q | Quarterly report |
| 2026-07-31 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-07-30 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-07-13 | 8-K | Results of operations |
| 2026-06-16 | 8-K | Regulation FD disclosure |
| 2026-06-15 | 8-K | Shareholder vote results |
| 2026-05-12 | 8-K | Results of operations |
| 2026-05-12 | 10-Q | Quarterly report |
| 2026-05-04 | 13G/A | Beneficial ownership report (5%+ holder) |
Alerts for $SNWV
Email me when SANUWAVE Health, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.